David Lebwohl
2020
In 2020, David Lebwohl earned a total compensation of $2.1M as Executive Vice President, Chief Medical Officer at Intellia Therapeutics.
Compensation breakdown
| Bonus | $228,000 |
|---|---|
| Option Awards | $1,549,720 |
| Salary | $298,378 |
| Other | $2,690 |
| Total | $2,078,788 |
Lebwohl received $1.5M in option awards, accounting for 75% of the total pay in 2020.
Lebwohl also received $228K in bonus, $298.4K in salary and $2.7K in other compensation.
Rankings
In 2020, David Lebwohl's compensation ranked 5,339th out of 13,090 executives tracked by ExecPay. In other words, Lebwohl earned more than 59.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,339 out of 13,090 | 59th |
Division Manufacturing | 2,194 out of 5,617 | 61st |
Major group Chemicals And Allied Products | 878 out of 2,248 | 61st |
Industry group Drugs | 756 out of 1,948 | 61st |
Industry In Vitro and In Vivo Diagnostic Substances | 11 out of 60 | 82nd |
Source: SEC filing on May 2, 2022.
Lebwohl's colleagues
We found three more compensation records of executives who worked with David Lebwohl at Intellia Therapeutics in 2020.